Wolf, Yochai
Anderson, Ana C.
Kuchroo, Vijay K.
Article History
Accepted: 9 September 2019
First Online: 1 November 2019
Competing interests
: A.C.A. is a member of the scientific advisory boards for Compass Therapeutics, Tizona Therapeutics and Zumutor Biologics, which have interests in cancer immunotherapy. A.C.A. is also a paid consultant for Aximmune. V.K.K. has an ownership interest in and is a member of the scientific advisory board for Tizona Therapeutics. V.K.K. is a co-founder of and has an ownership interest in Celsius Therapeutics. A.C.A.’s and V.K.K.’s interests were reviewed and managed by the Brigham and Women’s Hospital and Partners Healthcare in accordance with their conflict of interest policies. A.C.A. and V.K.K. are named inventors on patents related to TIM3.
Free to read: This content has been made available to all.